In the meantime, Cantor Fitzgerald initiated its Microvision Inc [MVIS] rating to a Neutral in a research note published on March 07, 2022; the price target was $5. A number of analysts have revised their coverage, including Ladenburg Thalmann’s analysts, who began to cover the stock in late January with a ‘”a Buy”‘ rating. Rodman & Renshaw began covering MVIS with “Buy” recommendation on December 17, 2015. Northland Capital maintained its rating on November 13, 2013. It rated MVIS as “an Outperform”.
Price Performance Review of MVIS
On Tuesday, Microvision Inc [NASDAQ:MVIS] saw its stock jump 0.72% to $1.40. Over the last five days, the stock has lost -14.63%. Microvision Inc shares have risen nearly 6.87% since the year began. Nevertheless, the stocks have fallen -47.37% over the past one year. While a 52-week high of $2.80 was reached on 01/07/25, a 52-week low of $0.80 was recorded on 01/02/25. SMA at 50 days reached $1.0318, while 200 days put it at $1.1550.
Levels Of Support And Resistance For MVIS Stock
The 24-hour chart illustrates a support level at 1.3000, which if violated will result in even more drops to 1.2000. On the upside, there is a resistance level at 1.5600. A further resistance level may holdings at 1.7200. The Relative Strength Index (RSI) on the 14-day chart is 61.38, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.1901, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 34.79%. Stochastics %K at 68.48% indicates the stock is a holding.
How much short interest is there in Microvision Inc?
A steep rise in short interest was recorded in Microvision Inc stocks on 2024-12-13, growing by 2.89 million shares to a total of 49.85 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 46.97 million shares. There was a rise of 5.8%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on March 07, 2013 when Northland Capital resumed its ‘”an Outperform”‘ rating for the stock and retained the price target to $4.
